Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TTRX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTurn Therapeutics files routine disclosure referencing press release
Filed June 1, 2026 · Period ending June 1, 2026 · ~1 min read
Key Changes
-
low
Company issued press release on June 1, 2026, furnished under Regulation FD disclosure requirements. Content details are in Exhibit 99.1, not disclosed in the 8-K body.
Item 7.01 verify on EDGAR →
Summary
Turn Therapeutics filed an 8-K on June 1, 2026, to disclose the issuance of a press release under Regulation FD. The filing is procedural in nature, referencing the press release as Exhibit 99.1 without providing details about its content within the 8-K itself. This type of filing is routine and typically used to satisfy disclosure requirements when companies make public announcements.
For retail investors, the actual substance of this disclosure depends entirely on the content of the press release, which is not included in the filing text provided. The 8-K serves primarily as a formal notification mechanism. Investors should review the actual press release (Exhibit 99.1) to understand what was announced and assess its potential impact on the company's business, financial position, or stock value.
Section-by-Section Diff
Event · Item 7.01 — Regulation FD Disclosure
Item 7.01 — Regulation FD Disclosure filed; see Key Changes for terms.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
On June 1, 2026, Turn Therapeutics Inc. issued a press release (the “Press Release”). A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The company issued a press release on June 1, 2026, which is attached as Exhibit 99.1.Without the exhibit content, the materiality and investor impact cannot be determined from this filing alone.
Event · Item 9.01 — Financial Statements and Exhibits
Turn Therapeutics filed an 8-K referencing a press release dated June 1, 2026, with no material business details disclosed in the filing itself.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
99.1
Press Release, dated June 1, 2026
The 8-K references an attached press release dated June 1, 2026, but provides no details about its content within the filing body. The actual substance of the disclosure would be in Exhibit 99.1, which is not included in the provided text.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 1, 2026 · How we verify